波兰胃癌患者中 Epstein-Barr 病毒合并感染的研究——一项初步研究。

Department of Biomedicine and Genetics, Chair of Biology and Medical Microbiology, Medical University of Lodz, Lodz, Poland.

2nd Oncological Surgery Ward - Oncologic Surgery Clinic, Provincial Multispeciality Center of Oncology and Traumatology named after M. Kopernik in Lodz, Lodz, Poland.

Pol J Microbiol. 2022 Feb 27;71(1):123-129. doi: 10.33073/pjm-2022-004.

The infectious agents may be the etiological factor of up to 15-20% of cancers. In stomach cancer, attention is paid to and Epstein-Barr virus, both of which cause gastritis and can lead to tumor development. In co-infection, the inflammatory process is much more intense. We assessed the seroprevalence towards and EBV in 32 patients with diagnosed gastric cancer. antibodies were found in 69% patients, and anti-EBV - in all of them. The study confirmed that co-infection of and EBV seems to be important in etiopathology of gastric cancer.

传染因子可能是多达 15-20%癌症的病因。在胃癌中，人们关注和 Epstein-Barr 病毒，这两种病毒都会导致胃炎，并且可能导致肿瘤发展。在合并感染中，炎症过程更加剧烈。我们评估了 32 名确诊胃癌患者的血清对和 EBV 的流行率。发现抗体存在于 69%的患者中，抗 EBV - 则存在于所有患者中。该研究证实，和 EBV 的合并感染似乎在胃癌的病因学中很重要。